Stocksigma LogoStocksigma Logo

Zota Health Care Reports Strong Q2FY27 Revenue Growth and Sequential EBITDA Turnaround

Zota Health Care reported a 54.58% YoY rise in consolidated revenue from operations to ₹19,933.14 lakhs for Q2FY27 ending 30th Sep'26, driven by a 76.25%

Zota Health Care Reports Strong Q2FY27 Revenue Growth and Sequential EBITDA Turnaround

Zota Health Care Ltd · Press Release · 28 Oct 2026, 11:47 pm

Zota Health Care Reports Strong Q2FY27 Revenue Growth and Sequential EBITDA Turnaround Zota Health Care reported a 54.58% YoY rise in consolidated revenue from operations to ₹19,933.14 lakhs for Q2FY27 ending 30th Sep'26, driven by a 76.25% YoY jump in Davaindia sales to ₹16,846.81 lakhs. EBITDA achieved a sharp sequential turnaround to ₹791.72 lakhs (3.97% margin) from a loss of ₹955.40 lakhs in Q1FY27. Davaindia reached 2,840 stores nationwide, generating quarterly GMV of ₹18,791 lakhs. Additionally, the company converted ₹119.52 crore of DHML debt into equity via preferential share allotment.

Original exchange filing (PDF)

More announcements from Zota Health Care Ltd

All Zota Health Care Ltd announcements